BBIO logo

BridgeBio Pharma, Inc. (BBIO) Free Cash Flow

Annual FCF:

-$529.63M-$608.00K(-0.11%)
December 31, 2024

Summary

  • As of today, BBIO annual free cash flow is -$529.63 million, with the most recent change of -$608.00 thousand (-0.11%) on December 31, 2024.
  • During the last 3 years, BBIO annual free cash flow has risen by +$16.55 million (+3.03%).
  • BBIO annual free cash flow is now -1193.30% below its all-time high of -$40.95 million, reached on December 31, 2017.

Performance

1-Year Change

-0.11%

3-Year Change

+3.03%

5-Year Change

-106.71%

15-Year Change

-1193.3%

BBIO Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

1.09%
BBIO annual free cash flow is higher than 1.09% of companies in Healthcare sector

Range

All-Time High

-$40.95M
BBIO annual free cash flow is currently -1193.30% below its historical high of -$40.95 million

3-Year Low

-$546.18M
BBIO annual free cash flow is currently +3.03% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BBIO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
BBIO next annual earnings announcement has not yet been scheduled

OtherBBIOcash flow metrics

Annual CFO

-$520.73M
BBIO annual cash from operations is -$520.73 million

Annual CFF

$748.46M
BBIO annual cash from financing is $748.46 million

Annual CFI

$60.78M
BBIO annual cash from investing is $60.78 million

Annual CAPEX

$8.91M
BBIO annual capital expenditures is $8.91 million

Quarterly FCF:

-$85.78M+$115.06M(+57.29%)
June 30, 2025

Summary

  • As of today, BBIO quarterly free cash flow is -$85.78 million, with the most recent change of +$115.06 million (+57.29%) on June 30, 2025.
  • Over the past year, BBIO quarterly free cash flow has dropped by -$158.03 million (-218.71%).
  • BBIO quarterly free cash flow is now -218.71% below its all-time high of $72.26 million, reached on June 30, 2024.

Performance

3-Month Change

+57.29%

1-Year Change

-218.71%

3-Year Change

-149.67%

5-Year Change

+2.74%

BBIO Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

3.25%
BBIO quarterly free cash flow is higher than 3.25% of companies in Healthcare sector

Range

All-Time High

$72.26M
BBIO quarterly free cash flow is currently -218.71% below its historical high of $72.26 million

3-Year Low

-$221.03M
BBIO quarterly free cash flow is currently +61.19% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BBIO previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 29, 2025
BBIO next earnings announcement is scheduled for Oct 29, 2025

OtherBBIOcash flow metrics

Quarterly CFO

-$80.68M
BBIO quarterly cash from operations is -$80.68 million

Quarterly CFF

$302.04M
BBIO quarterly cash from financing is $302.04 million

Quarterly CFI

-$13.00M
BBIO quarterly cash from investing is -$13.00 million

Quarterly CAPEX

$5.09M
BBIO quarterly capital expenditures is $5.09 million

TTM FCF:

-$667.47M-$158.03M(-31.02%)
June 30, 2025

Summary

  • As of today, BBIO TTM free cash flow is -$667.47 million, with the most recent change of -$158.03 million (-31.02%) on June 30, 2025.
  • Over the past year, BBIO TTM free cash flow has dropped by -$247.78 million (-59.04%).
  • BBIO TTM free cash flow is now -1914.81% below its all-time high of -$33.13 million, reached on March 31, 2018.

Performance

3-Month Change

-31.02%

1-Year Change

-59.04%

3-Year Change

-34.76%

5-Year Change

-73.69%

BBIO TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

0.63%
BBIO TTM free cash flow is higher than 0.63% of companies in Healthcare sector

Range

All-Time High

-$33.13M
BBIO TTM free cash flow is currently -1914.81% below its historical high of -$33.13 million

3-Year Low

-$667.47M
BBIO TTM free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BBIO previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 29, 2025
BBIO next earnings announcement is scheduled for Oct 29, 2025

OtherBBIOcash flow metrics

TTM CFO

-$655.81M
BBIO TTM cash from operations is -$655.81 million

TTM CFF

$837.01M
BBIO TTM cash from financing is $837.01 million

TTM CFI

$20.39M
BBIO TTM cash from investing is $20.39 million

TTM CAPEX

$11.66M
BBIO TTM capital expenditures is $11.66 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$529.63M
BBIO annual free cash flow is -$529.63 million

Annual CFO

-$520.73M
BBIO annual cash from operations is -$520.73 million

Annual CAPEX

$8.91M
BBIO annual capital expenditures is $8.91 million

BBIO Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-0.1%-218.7%-59.0%
3Y3 Years+3.0%-149.7%-34.8%
5Y5 Years-106.7%+2.7%-73.7%

BBIO Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-24.4%+3.0%-218.7%+61.2%-63.3%at low
5Y5-Year-106.7%+3.0%-218.7%+61.2%-73.7%at low
All-TimeAll-Time-1193.3%+3.0%-218.7%+61.2%-1914.8%at low

BBIO Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$85.78M(+57.3%)
-$667.47M(-31.0%)
Mar 2025
-
-$200.83M(-1.1%)
-$509.44M(+3.8%)
Dec 2024
-$529.63M(-0.1%)
-$198.56M(-8.9%)
-$529.63M(-16.1%)
Sep 2024
-
-$182.30M(-352.3%)
-$456.32M(-8.7%)
Jun 2024
-
$72.26M(+132.7%)
-$419.68M(+30.7%)
Mar 2024
-
-$221.03M(-76.5%)
-$605.72M(-14.5%)
Dec 2023
-$529.03M(-24.2%)
-$125.25M(+14.0%)
-$529.03M(-6.3%)
Sep 2023
-
-$145.66M(-28.0%)
-$497.82M(-2.0%)
Jun 2023
-
-$113.78M(+21.2%)
-$488.08M(-19.4%)
Mar 2023
-
-$144.33M(-53.5%)
-$408.65M(+4.0%)
Dec 2022
-$425.81M(+22.0%)
-$94.04M(+30.8%)
-$425.81M(+9.1%)
Sep 2022
-
-$135.92M(-295.6%)
-$468.20M(+5.5%)
Jun 2022
-
-$34.35M(+78.7%)
-$495.30M(+10.7%)
Mar 2022
-
-$161.49M(-18.4%)
-$554.95M(-1.6%)
Dec 2021
-$546.18M
-$136.43M(+16.3%)
-$546.18M(-7.5%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$163.02M(-73.4%)
-$508.16M(-6.4%)
Jun 2021
-
-$94.00M(+38.5%)
-$477.37M(-1.2%)
Mar 2021
-
-$152.73M(-55.2%)
-$471.56M(-15.8%)
Dec 2020
-$407.23M(-58.9%)
-$98.41M(+25.6%)
-$407.23M(-6.0%)
Sep 2020
-
-$132.23M(-49.9%)
-$384.27M(-27.1%)
Jun 2020
-
-$88.19M(+0.2%)
-$302.42M(-6.8%)
Mar 2020
-
-$88.40M(-17.2%)
-$283.06M(-10.5%)
Dec 2019
-$256.23M(-65.5%)
-$75.45M(-49.8%)
-$256.23M(-12.4%)
Sep 2019
-
-$50.38M(+26.8%)
-$227.93M(-5.3%)
Jun 2019
-
-$68.83M(-11.8%)
-$216.48M(-18.1%)
Mar 2019
-
-$61.57M(-30.6%)
-$183.26M(-18.4%)
Dec 2018
-$154.82M(-278.1%)
-$47.16M(-21.1%)
-$154.82M(-43.8%)
Sep 2018
-
-$38.93M(-9.3%)
-$107.67M(-56.6%)
Jun 2018
-
-$35.61M(-7.5%)
-$68.74M(-107.5%)
Mar 2018
-
-$33.13M
-$33.13M
Dec 2017
-$40.95M
-
-

FAQ

  • What is BridgeBio Pharma, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual free cash flow year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly free cash flow year-on-year change?
  • What is BridgeBio Pharma, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. TTM free cash flow year-on-year change?

What is BridgeBio Pharma, Inc. annual free cash flow?

The current annual free cash flow of BBIO is -$529.63M

What is the all-time high annual free cash flow for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual free cash flow is -$40.95M

What is BridgeBio Pharma, Inc. annual free cash flow year-on-year change?

Over the past year, BBIO annual free cash flow has changed by -$608.00K (-0.11%)

What is BridgeBio Pharma, Inc. quarterly free cash flow?

The current quarterly free cash flow of BBIO is -$85.78M

What is the all-time high quarterly free cash flow for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly free cash flow is $72.26M

What is BridgeBio Pharma, Inc. quarterly free cash flow year-on-year change?

Over the past year, BBIO quarterly free cash flow has changed by -$158.03M (-218.71%)

What is BridgeBio Pharma, Inc. TTM free cash flow?

The current TTM free cash flow of BBIO is -$667.47M

What is the all-time high TTM free cash flow for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high TTM free cash flow is -$33.13M

What is BridgeBio Pharma, Inc. TTM free cash flow year-on-year change?

Over the past year, BBIO TTM free cash flow has changed by -$247.78M (-59.04%)
On this page